Tai W Wong

Title: The Innovations of Tai W Wong

Introduction

Tai W Wong is a notable inventor based in Belle Meade, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic models for cancer research. With a total of 2 patents, Wong's work has the potential to impact cancer treatment significantly.

Latest Patents

Wong's latest patents include "Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors." This invention describes a transgenic non-human mammal whose germ cells and somatic cells contain a constructively activated tyrosine kinase receptor. This receptor is introduced into the mammal, or an ancestor of the mammal, at an embryonic stage. These transgenic non-human mammals can serve as ligand-independent in vivo models for identifying and developing selective tyrosine kinase modulators for cancer treatment. Another significant patent is "Pyrrolotriazine kinase inhibitors," which comprises compounds useful as protein kinase inhibitors. These compounds are beneficial for treating cancer and other diseases mediated by protein kinases.

Career Highlights

Wong is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the field of cancer research. His work focuses on developing new therapeutic strategies that can lead to better treatment options for patients.

Collaborations

Wong has collaborated with esteemed colleagues such as Robert Michael Borzilleri and Zhong Chen. These collaborations have further enhanced the research and development of innovative solutions in the biotechnology sector.

Conclusion

Tai W Wong's contributions to biotechnology and cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer treatment and therapeutic development.